Richard W. Light

Q: What Schools Are Affiliated With Richard W. Light

Richard W. Light is affiliated with the following schools: Vanderbilt University, University of São Paulo

Richard W. Light's AcademicInfluence.com Rankings

Richard W. Light

Philosophy

#3844

World Rank

#6140

Historical Rank

Logic

#1451

World Rank

#2206

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Richard W. Light's Degrees

Doctorate Medicine Harvard University

Why Is Richard W. Light Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Richard W. Light's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial (2008) (1752)
Pleural effusions: the diagnostic separation of transudates and exudates. (1972) (1567)
Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. (2001) (1047)
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. (1999) (733)
Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. (2000) (626)
Clinical practice. Pleural effusion. (2002) (571)
Pleural diseases. (1992) (463)
The Superior Vena Cava Syndrome: Clinical Characteristics and Evolving Etiology (2006) (399)
A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions (1999) (369)
Update on tuberculous pleural effusion (2010) (348)
Cells in pleural fluid. Their value in differential diagnosis. (1973) (313)
Ultrasound-guided thoracentesis: is it a safer method? (2003) (311)
Thoracoscopy talc poudrage : a 15-year experience. (2001) (296)
Parapneumonic effusions. (1980) (289)
Parapneumonic effusions and empyema. (2006) (279)
Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. (1985) (272)
Diagnostic approach to pleural effusion in adults. (2006) (239)
The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia. (1993) (212)
Serial pulmonary function in patients with acute heart failure. (1983) (211)
Pressure-time product during continuous positive airway pressure, pressure support ventilation, and T-piece during weaning from mechanical ventilation. (1991) (210)
Textbook of Pleural Diseases (2008) (202)
Diagnostic principles in pleural disease. (1997) (200)
Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax. Results of a Department of Veterans Affairs cooperative study. (1990) (195)
Management of spontaneous pneumothorax. (1993) (192)
Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients* (2007) (191)
Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. (2003) (190)
Airway occlusion pressure. An important indicator for successful weaning in patients with chronic obstructive pulmonary disease. (1987) (187)
Diagnostic significance of pleural fluid pH and PCO2. (1973) (184)
Parapneumonic effusion and empyema. (1997) (183)
Triazolam in patients with obstructive sleep apnea. (1995) (173)
Reanalysis of the 12-minute walk in patients with chronic obstructive pulmonary disease. (1994) (163)
Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990. (1995) (156)
[Parapneumonic effusions and empyema]. (1985) (154)
Respiratory failure due to insufflated talc (1997) (151)
Randomized Trial of Pleural Fluid Drainage Frequency in Patients with Malignant Pleural Effusions. The ASAP Trial (2017) (148)
Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. (1989) (147)
Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions (2003) (146)
Observations on pleural fluid pressures as fluid is withdrawn during thoracentesis. (2015) (143)
Pleural tuberculosis in the United States: incidence and drug resistance. (2007) (139)
Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. (2002) (134)
Evolution of idiopathic pleural effusion: a prospective, long-term follow-up study. (1996) (134)
Clinical features and survival of lung cancer patients with pleural effusions (2015) (131)
A new classification of parapneumonic effusions and empyema. (1995) (131)
Talc preparations used for pleurodesis vary markedly from one preparation to another. (2001) (127)
Factors related to recurrence of spontaneous pneumothorax (2005) (120)
Vascular endothelial growth factor in pleural fluid. (1999) (113)
Effect of upper airway anesthesia on obstructive sleep apnea. (1995) (111)
Iodopovidone pleurodesis for recurrent pleural effusions. (2002) (110)
Hemodynamics of patients with severe chronic obstructive pulmonary disease during progressive upright exercise. (2015) (106)
Parapneumonic effusions and empyema. (2000) (106)
Large Pleural Effusions Occurring after Coronary Artery Bypass Grafting (1999) (106)
Comparison of the effectiveness of tetracycline and minocycline as pleural sclerosing agents in rabbits. (1994) (105)
Prevalence and clinical course of pleural effusions at 30 days after coronary artery and cardiac surgery. (2002) (104)
The relationship between pleural fluid findings and the development of pleural thickening in patients with pleural tuberculosis. (1991) (103)
Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions. (2005) (103)
Chylothorax and pseudochylothorax. (1985) (102)
Significance of iatrogenic pneumothoraces. (1994) (98)
Factors associated with prolonged mechanical ventilation following coronary artery bypass surgery. (2001) (97)
Upper airway anesthesia reduces phasic genioglossus activity during sleep apnea. (1997) (96)
Management of parapneumonic effusions. (1981) (94)
Postoperative pleural changes after coronary revascularization. Comparison between saphenous vein and internal mammary artery grafting. (1992) (92)
The In Vitro Efficacy of Varidase Versus Streptokinase or Urokinase for Liquefying Thick Purulent Exudative Material from Loculated Empyema (2000) (91)
Incidence and aetiology of eosinophilic pleural effusion (2009) (91)
Arterial blood gases after coronary artery bypass surgery. (1992) (88)
Glucose and amylase in pleural effusions. (1973) (87)
Transforming Growth Factor β Induces Vascular Endothelial Growth Factor Elaboration from Pleural Mesothelial Cells in Vivo and in Vitro (2002) (86)
Antibiotic levels in empyemic pleural fluid. (2000) (84)
Useful tests on the pleural fluid in the management of patients with pleural effusions. (1999) (84)
Pleural controversy: Optimal chest tube size for drainage (2011) (83)
A single intrapleural injection of transforming growth factor-beta(2) produces an excellent pleurodesis in rabbits. (2000) (82)
Sleep apnea impairs the arousal response to airway occlusion. (1996) (81)
Comparison of pleural fluid pH values obtained using blood gas machine, pH meter, and pH indicator strip. (1998) (80)
The one best test for evaluating the effects of bronchodilator therapy. (1977) (80)
Nuclear Factor-κB Affects Tumor Progression in a Mouse Model of Malignant Pleural Effusion (2006) (80)
The relationship between pleural pressures and changes in pulmonary function after therapeutic thoracentesis. (2015) (80)
Talc should not be used for pleurodesis. (2000) (79)
Solving the Light's criteria misclassification rate of cardiac and hepatic transudates (2012) (77)
Tumor Necrosis Factor-α Promotes Malignant Pleural Effusion (2007) (76)
Inspiratory work of breathing on flow-by and demand-flow continuous positive airway pressure. (1989) (76)
Inspiratory muscle work of breathing during flow-by, demand-flow, and continuous-flow systems in patients with chronic obstructive pulmonary disease. (1992) (74)
Doxepin treatment of depressed patients with chronic obstructive pulmonary disease. (1986) (74)
Management of malignant pleural effusions (2004) (73)
Effect of hyperoxia on the arousal response to airway occlusion during sleep in normal subjects. (1992) (73)
Pleural effusions due to dasatinib (2010) (72)
Systemic corticosteroids decrease the effectiveness of talc pleurodesis. (1998) (72)
Pulmonary function after coronary artery bypass surgery. (1997) (72)
Iatrogenic Pneumothorax: Etiology and Morbidity (1992) (71)
Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD. (1989) (71)
Effect of radiation therapy on bronchial obstruction due to bronchogenic carcinoma. (1989) (71)
Transforming growth factor-beta2 induces pleurodesis significantly faster than talc. (2001) (71)
Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. (1993) (69)
Vascular endothelial growth factor level correlates with transforming growth factor-beta isoform levels in pleural effusions. (2000) (67)
Human alveolar macrophages suppress the proliferative response of peripheral blood lymphocytes. (1982) (66)
Pleural fluid characteristics of patients with symptomatic pleural effusion after coronary artery bypass graft surgery. (2000) (66)
Talc for pleurodesis? (2002) (66)
Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions. (2001) (65)
Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient. (1993) (65)
Serial pleural fluid analysis in a new experimental model of empyema. (1996) (64)
Management of malignant pleural mesothelioma: a critical review (2000) (64)
Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. (2006) (64)
Pleural Sclerosis for the Treatment of Pneumothorax and Pleural Effusion (1997) (64)
Effectiveness of bleomycin in comparison to tetracycline as pleural sclerosing agent in rabbits. (1993) (63)
Relationship between pleural effusion and pericardial involvement after myocardial revascularization. (1994) (63)
Effi cacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial (2008) (63)
Intrapleural talc for the prevention of recurrence in benign or undiagnosed pleural effusions. (1994) (63)
Management of parapneumonic effusions. (1998) (62)
Routine measurement of pleural fluid amylase is not indicated. (2001) (61)
Alternative widely available, inexpensive agents for pleurodesis (2005) (61)
The sun should never set on a parapneumonic effusion. (1989) (60)
Symptomatic persistent post-coronary artery bypass graft pleural effusions requiring operative treatment : clinical and histologic features. (2001) (60)
Pleural effusions. (2011) (60)
Origin of pleural fluid amylase in esophageal rupture. (1972) (59)
Diseases of the pleura. (1997) (59)
Effect of ethanol on the efficacy of nasal continuous positive airway pressure as a treatment for obstructive sleep apnea. (2005) (59)
Malignant pleural effusion: would the real cause please stand up? (1997) (58)
Etiology and prognostic significance of massive pleural effusions. (2005) (58)
Comparison of polymorphonuclear- and lymphocyte-rich tuberculous pleural effusions. (2013) (58)
Effect of theophylline on sleep and sleep-disordered breathing in patients with chronic obstructive pulmonary disease. (1991) (57)
Relationship between pleural changes after myocardial revascularization and pulmonary mechanics. (1992) (57)
The effect of triazolam on the arousal response to airway occlusion during sleep in normal subjects. (1992) (56)
Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusions. (2015) (56)
Analysis of pleural effusions in acute pulmonary embolism: Radiological and pleural fluid data from 230 patients (2007) (56)
Tumor necrosis factor-alpha promotes malignant pleural effusion. (2007) (55)
Pleural effusions after coronary artery bypass graft surgery (2002) (55)
Comparison of silver nitrate and tetracycline as pleural sclerosing agents in rabbits. (1995) (54)
Comparison of the end-tidal arterial PCO2 gradient during exercise in normal subjects and in patients with severe COPD. (1995) (54)
Effect of 30 mg of morphine alone or with promethazine or prochlorperazine on the exercise capacity of patients with COPD. (1996) (54)
Intrapleural talc for the prevention of recurrent pneumothorax. (1994) (53)
Arterial blood gas changes during breath-holding from functional residual capacity. (1996) (53)
Silver nitrate is superior to talc slurry in producing pleurodesis in rabbits. (2000) (52)
Variations in pleural fluid WBC count and differential counts with different sample containers and different methods. (2003) (52)
Management of pleural effusions. (2000) (51)
Pathogenesis of the eosinophilic pleural effusions (2004) (50)
Incidence and significance of pleural effusion after abdominal surgery. (1976) (50)
Talc slurry is an effective pleural sclerosant in rabbits. (1995) (50)
Routine monitoring with pleural manometry during therapeutic large-volume thoracentesis to prevent pleural-pressure-related complications: a multicentre, single-blind randomised controlled trial. (2019) (49)
Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio) (2015) (49)
Hypoxemia during exercise in patients with chronic obstructive pulmonary disease. (2015) (49)
What is the origin of pleural transudates and exudates? (1992) (48)
The effects of early chest tube placement on empyema resolution. (1997) (48)
Pulmonary cryptococcosis in non-AIDS patients. (2012) (48)
Eosinophilic pleural effusions. (2003) (47)
Determining the optimal number of specimens to obtain with needle biopsy of the pleura. (2002) (47)
Identification of pulmonary hypertension in chronic obstructive pulmonary disease from routine chest radiographs. (1982) (46)
Clinical and roentgenographic manifestations of acute and chronic blastomycosis. (1976) (46)
Pleural effusion due to pulmonary emboli. (2001) (46)
Transforming growth factor‐β induces collagen synthesis without inducing IL‐8 production in mesothelial cells (2003) (46)
Effect of ethanol on the arousal response to airway occlusion during sleep in normal subjects. (1992) (45)
Influence of atelectasis on pulmonary function after coronary artery bypass grafting. (1993) (45)
Talc and silver nitrate induce systemic inflammatory effects during the acute phase of experimental pleurodesis in rabbits. (2004) (45)
Effects of diuresis on the characteristics of pleural fluid in patients with congestive heart failure. (1990) (45)
Pneumothorax, Chylothorax, Hemothorax and Fibrothorax (2005) (45)
Iatrogenic pneumothorax: etiology and morbidity. Results of a Department of Veterans Affairs Cooperative Study. (1992) (44)
Establishing the diagnosis of tuberculous pleuritis. (1998) (44)
Prognostic features of residual pleural thickening in parapneumonic pleural effusions (2003) (44)
The pleura: the outer space of pulmonary medicine. (1997) (43)
Improved exercise tolerance of the polycythemic lung patient following phlebotomy. (1983) (43)
Antinuclear antibody testing in pleural fluid for the diagnosis of lupus pleuritis (2007) (43)
The undiagnosed pleural effusion. (2006) (42)
The efficacy of chest radiographs in detecting parapneumonic effusions (2011) (42)
Effect of desipramine on control of ventilation and depression scores in patients with severe chronic obstructive pulmonary disease (1985) (42)
Pleural disease and acquired immune deficiency syndrome. (1997) (41)
Work of breathing and airway occlusion pressure during assist-mode mechanical ventilation. (1988) (40)
Treatment of chronic obstructive pulmonary disease with corticosteroids. Comparison of daily vs alternate-day therapy. (1984) (40)
Relationship between improvement in exercise performance with supplemental oxygen and hypoxic ventilatory drive in patients with chronic airflow obstruction. (1989) (39)
Prevalence and characteristics of pleural effusions in superior vena cava syndrome (2006) (38)
The effect of corticosteroids on pleurodesis induced by doxycycline in rabbits. (2002) (38)
Tumor markers in undiagnosed pleural effusions. (2004) (38)
Frequency of pleural effusions in patients with pulmonary arterial hypertension associated with connective tissue diseases. (2010) (38)
Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion. (2006) (37)
Prevention of suctioning-related arterial oxygen desaturation. Comparison of off-ventilator and on-ventilator suctioning (1983) (37)
The utility of daily therapeutic thoracentesis for the treatment of early empyema. (1999) (37)
Experimental pleurodesis in rabbits induced by silver nitrate or talc: 1-year follow-up. (2001) (36)
Diagnostic value of pleural fluid N‐terminal pro‐brain natriuretic peptide levels in patients with cardiovascular diseases (2008) (36)
Angiopoietin-2 levels are elevated in exudative pleural effusions. (2006) (36)
Increased serum theophylline clearance with orally administered activated charcoal. (1983) (36)
Pleural effusions. (2013) (36)
Diseases of the pleura: the use of talc for pleurodesis (2000) (35)
Reproducibility of VO2max in patients with chronic air-flow obstruction. (1985) (35)
Routine use of pleural fluid cultures. Are they indicated? Limited yield, minimal impact on treatment decisions. (2006) (35)
A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT (2015) (34)
Should the FVC be considered in evaluating response to bronchodilator? (1983) (34)
BAL neopterin : a novel marker for cell-mediated immunity in patients with pulmonary tuberculosis and lung cancer. (2001) (34)
Pleural effusions following cardiac injury and coronary artery bypass graft surgery. (2001) (33)
Transforming growth factor β2 induced pleurodesis is not inhibited by corticosteroids (2001) (33)
Pleural Fluid Parameters Identifying Complicated Parapneumonic Effusions (2005) (31)
Pleural Effusion in Meigs’ Syndrome—Transudate or Exudate? (2015) (31)
Pleural effusion in pulmonary embolism. (2010) (31)
Effects of high- and low-carbohydrate meals on maximum exercise performance in chronic airflow obstruction. (1991) (31)
Tuberculous Pleural Effusion. (2015) (31)
Acute pleuropulmonary complications detected by computed tomography following myocardial revascularization. (2002) (31)
Comparison of oxygen saturation by pulse oximetry and co-oximetry during exercise testing in patients with COPD. (1996) (31)
Incidence of pleural effusions in idiopathic and familial pulmonary arterial hypertension patients. (2009) (30)
Computed tomography scoring system for discriminating between parapneumonic effusions eventually drained and those cured only with antibiotics (2017) (30)
Effects of verapamil on pulmonary haemodynamics during hypoxaemia, at rest, and during exercise in patients with chronic obstructive pulmonary disease. (1983) (29)
Effects of a large carbohydrate load on walking performance in chronic air-flow obstruction. (1985) (29)
Counterpoint: should thoracoscopic talc pleurodesis be the first choice management for malignant pleural effusion? No. (2012) (29)
Exercise performance following a carbohydrate load in chronic airflow obstruction. (1985) (29)
Effect of hypercapnia on the arousal response to airway occlusion during sleep in normal subjects. (1993) (28)
Etiology of carbon dioxide retention at rest and during exercise in chronic airflow obstruction. (1988) (28)
Penetration of newer quinolones in the empyema fluid (2004) (28)
Comparing transforming growth factor‐β2, talc and bleomycin as pleurodesing agents in sheep (2002) (28)
Pleural effusions due to pulmonary embolism (2008) (28)
Transforming growth factor beta induces vascular endothelial growth factor elaboration from pleural mesothelial cells in vivo and in vitro. (2002) (28)
Effects of digoxin on exercise capacity and right ventricular function during exercise in chronic airflow obstruction. (1984) (28)
Pleuroscopy or video-assisted thoracoscopic surgery for exudative pleural effusion: a comparative overview. (2019) (28)
Continuous oxygen monitoring--a better way to prescribe long-term oxygen therapy. (2005) (28)
Effect of inhaled furosemide on the bronchial response to lysine-aspirin inhalation in asthmatic subjects. (1992) (27)
Subclinical surface alterations of human pleura. A scanning electron microscopic study. (1994) (27)
Stability of adenosine deaminase during transportation. (2004) (27)
Assessing need for long-term oxygen therapy: a comparison of conventional evaluation and measures of ambulatory oximetry monitoring. (2003) (26)
Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients. (2007) (26)
Manual aspiration: the preferred method for managing primary spontaneous pneumothorax? (2002) (26)
Effect of naloxone on maximal exercise performance and control of ventilation in COPD. (1989) (26)
Temporal evolution of pleural fibrosis induced by intrapleural minocycline injection. (1995) (25)
The angiopoietin/Tie2 axis mediates malignant pleural effusion formation. (2009) (25)
Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer (1995) (25)
Exercise performance with added dead space in chronic airflow obstruction. (1984) (25)
Prevention of suctioning-related arterial oxygen desaturation. Comparison of off-ventilator and on-ventilator suctioning. (1984) (25)
Fiberoptic bronchoscopy in the diagnosis of pulmonary fungal and nocardial infarctions. (1978) (24)
Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count) (2016) (24)
Relationship between pleural fluid and serum cholesterol levels. (2001) (24)
Chylothoraces after lung transplantation for lymphangioleiomyomatosis: review of the literature and utilization of a pleurovenous shunt. (2007) (24)
Unexpandable lung from pleural disease (2018) (24)
Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels. (2009) (23)
Iodopovidone is as effective as doxycycline in producing pleurodesis in rabbits (2010) (23)
An Observational Study Evaluating the Performance of LENT Score in the Selected Population of Malignant Pleural Effusion from Lung Adenocarcinoma in Singapore (2018) (23)
Unilateral lymphocytic pleuritis as a manifestation of familial Mediterranean fever. (2008) (23)
Ventilator modes: old and new. (1990) (23)
Pleurodesis is inhibited by anti-vascular endothelial growth factor antibody. (2005) (23)
Effect of ethanol and naloxone on control of ventilation and load perception. (1983) (23)
Intrapleural low-dose silver nitrate elicits more pleural inflammation and less systemic inflammation than low-dose talc. (2005) (22)
Patient with bilateral pleural effusion: are the findings the same in each fluid? (2003) (22)
The management of parapneumonic effusions and empyema. (1998) (22)
What size parapneumonic effusions should be sampled? (2009) (21)
A 43-year-old man with a large recurrent right-sided pleural effusion. Diagnosis: Constrictive pericarditis. (2000) (21)
Transforming growth factor beta(2) (TGF beta(2)) produces effective pleurodesis in sheep with no systemic complications. (2000) (21)
Oral forms of tetracycline and doxycycline are effective in producing pleurodesis. (2005) (21)
Doxycycline pleurodesis in rabbits: comparison of results with and without chest tube. (1998) (21)
[Parapneumonic pleural effusions and empyema in adults:current practice]. (2009) (21)
Massive Pulmonary Emboli and CT Pulmonary Angiography (2008) (21)
Haloperidol and sudden death due to pulmonary edema. (1982) (21)
Chemokine involvement in tetracycline-induced pleuritis. (1999) (21)
Eotaxin-3 and interleukin-5 pleural fluid levels are associated with pleural fluid eosinophilia in post-coronary artery bypass grafting pleural effusions. (2005) (21)
The Effects of Intrapleural Polyclonal Anti-Tumor Necrosis Factor alpha (TNFα) Fab Fragments on Pleurodesis in Rabbits (2000) (20)
The Adult Respiratory Distress Syndrome and Pancuronium Bromide (1975) (20)
Alternate day steroid therapy in diffuse pulmonary sarcoidosis. (1973) (20)
Reversible melphalan-induced lung damage. (1980) (20)
Efficacy of ultrasound in the diagnosis of pleurodesis in rabbits. (2004) (19)
Bayesian analysis using continuous likelihood ratios for identifying pleural exudates. (2006) (19)
Black pleural effusion. (2013) (19)
Pleural fluid levels of interleukin-5 and eosinophils are closely correlated. (2002) (19)
Intrapleural streptokinase for pleural infection (2006) (19)
Penetration of Clarithromycin in Experimental Pleural Empyema Model Fluid (2005) (19)
Exercise performance of polycythemic chronic obstructive pulmonary disease patients. Effect of phlebotomies. (1990) (19)
Pleural space as a site of ectopic gene delivery: transfection of pleural mesothelial cells with systemic distribution of gene product. (2003) (19)
Contralateral tension pneumothorax following unilateral chest tube drainage of bilateral pneumothoraces in a heart-lung transplant patient. (1999) (18)
Comparison of the effects of labetalol and hydrochlorothiazide on the ventilatory function of hypertensive patients with mild chronic obstructive pulmonary disease. (1983) (17)
Management of Indwelling Tunneled Pleural Catheters: A Modified Delphi Consensus Statement. (2020) (17)
Pleural effusions occurring with right heart failure (2011) (17)
Arterial Oxygen Saturation During Meals in Patients With Severe Chronic Obstructive Pulmonary Disease (1983) (17)
Antimycobacterial antibody levels in pleural fluid as reflection of passive diffusion from serum. (1990) (17)
SINGLE-CHAIN UROKINASE IN EMPYEMA INDUCED BY PASTURELLA MULTOCIDA (2009) (17)
Pleural Lavage: A Novel Diagnostic Approach For Diagnosing Exudative Pleural Effusion (2000) (17)
Exudative pleural effusions secondary to gastrointestinal diseases. (1985) (17)
Effusions from infections: tuberculosis (2008) (17)
Proinflammatory and antiinflammatory cytokine levels in complicated and noncomplicated parapneumonic pleural effusions. (2012) (17)
Antibodies to mycobacterial peptidoglycolipid and to crude protein antigens in sera from different categories of human subjects (1988) (16)
Drug-induced eosinophilic pleural effusion (2011) (16)
Acute and Chronic Pleural Changes after the Intrapleural Instillation of Mitoxantrone in Rabbits (1998) (16)
Vertebral osteomyelitis due to Pseudomonas in the occasional heroin user. (1974) (16)
The relationship between arterial blood gases and serum theophylline clearance in critically ill patients. (1981) (16)
Does the hypoxic ventilatory response predict the oxygen-induced falls in ventilation in COPD? (1993) (15)
Serial Observations after High Dose Talc Slurry in the Rabbit Model for Pleurodesis (1998) (15)
Cardiopulmonary responses to exercise in chronic airflow obstruction. Effects of inhaled atropine sulfate. (1986) (15)
Activation of proteinase-activated receptor-2 in mesothelial cells induces pleural inflammation. (2005) (15)
Lactate dehydrogenase isoenzymes in pleural effusions. (1973) (15)
Safety and efficacy of using a surgivac pump for the drainage of chronic indwelling pleural catheters in malignant pleural effusions (2008) (15)
Chemical pleurodesis for malignant pleural effusion (2012) (15)
Road ahead to respiratory health: Experts chart future research directions (2009) (15)
Pleural fluid levels of vascular cell adhesion molecule-1 are elevated in eosinophilic pleural effusions. (2003) (14)
Diagnosing pleural effusion: moving beyond transudate-exudate separation. (2007) (14)
A new radiologic appearance of pulmonary thromboembolism: multiloculated pleural effusions. (2004) (14)
Management of parapneumonic effusions. (1976) (14)
Derrame pleural paraneumónico y empiema (2000) (14)
Combination therapy with intrapleural doxycycline and talc in reduced doses is effective in producing pleurodesis in rabbits. (2005) (13)
LDH and fibrinogen-fibrin degradation products in pulmonary embolism. (1974) (13)
Low Pleural Fluid pH in Parapneumonic Effusion (1975) (13)
Pneumothorax‐associated pleural eosinophilia is tumour necrosis factor‐alpha‐dependent and attenuated by steroids (2007) (13)
Pleural manometry-historical background, rationale for use and methods of measurement. (2018) (13)
PARA PNEUMONIC EFFUSIONS (1980) (13)
Lack of effect of dextromethorphan on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease (COPD). (1991) (13)
Comparing transforming growth factor beta‐2 and fibronectin as pleurodesing agents (2001) (13)
Comparison of nitrogen mustard, cytarabine and dacarbazine as pleural sclerosing agents in rabbits. (1997) (13)
Naloxone reverses ethanol-induced depression of hypercapnic drive. (2015) (12)
Transbronchial Needle Aspiration for Diagnosis of Sarcoidosis (2004) (12)
Late pulmonary function in survivors of adult respiratory distress syndrome. (1976) (12)
Pleural manometry in patients with pleural diseases - the usefulness in clinical practice. (2018) (12)
Falsely high refractometric readings for the specific gravity of pleural fluid. (1979) (12)
Development and validation of a scoring system for the identification of pleural exudates of cardiac origin. (2017) (12)
Comparisons of pleurodesis induced by talc with or without thymol iodide in rabbits. (1998) (12)
Indomethacin and perception of dyspnea in chronic airflow obstruction. (1988) (12)
Comparison of the effects of labetalol and hydrochlorothiazide on the ventilatory function of hypertensive patients with asthma and propranolol sensitivity. (1985) (12)
Editorial: Management of parapneumonic effusions. (1976) (12)
Corynebacterium parvum versus tetracycline as pleural sclerosing agents in rabbits. (1995) (11)
Pleurodesis: A novel experimental model (2007) (11)
Phase 1 trial of intrapleural LTI-01; single chain urokinase in complicated parapneumonic effusions or empyema. (2019) (11)
Diagnostic approach to pleural diseases: new tricks for an old trade (2017) (11)
Iatrogenic bilateral pneumothorax following unilateral transbronchial lung biopsy. (2006) (11)
Update: Management of the Difficult to Diagnose Pleural Effusion (2003) (11)
The short-term administration of Ketoprofen does not decrease the effect of Pleurodesis induced by talc or Doxycycline in rabbits. (2007) (11)
Low doses of silver nitrate induce pleurodesis with a limited systemic response (2009) (11)
Albuterol and isoproterenol in bronchial asthma. Efficacy and toxicity of drugs administered via intermittent positive pressure breathing. (1979) (10)
Comparison of pleural N‐terminal pro‐B‐type natriuretic peptide, midregion pro‐atrial natriuretic peptide and mid‐region pro‐adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure (2013) (10)
A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels (2019) (10)
Pneumothorax-associated pleural eosinophilia in mice is interleukin-5 but not interleukin-13 dependent. (2005) (10)
Transforming growth factor-beta3 induces pleurodesis in rabbits and collagen production of human mesothelial cells. (2005) (10)
Metabolic activity of pleural fluid. (1973) (10)
Phase I trial of the single-chain urokinase intrapleural LTI-01 in complicated parapneumonic effusions or empyema (2019) (10)
Diagnosis of pleural infection: state-of-the-art (2012) (9)
Cancer ratio and other new parameters for differentiation between malignant and nonmalignant pleural effusions. (2018) (9)
Monoclonal antibodies anti-TGFβ1 and anti-VEGF inhibit the experimental pleurodesis induced by silver nitrate (2012) (9)
Contarini's syndrome: bilateral pleural effusion, each side from different causes. (2012) (9)
Talc should not be used for pleurodesis in patients with nonmalignant pleural effusions. (2001) (9)
Ischemia modified albumin in the differential diagnosis of pleural effusions. (2011) (9)
USE OF PLEURAL FLUID C-REACTIVE PROTEIN LEVEL AS A DIAGNOSTIC MARKER FOR PLEURAL EFFUSIONS (2009) (9)
Comparison between conventional cap and one-way valve in the decannulation of patients with long-term tracheostomies (1993) (9)
Microscopic anatomy of the pleura. (2011) (9)
Vascular endothelial growth factor levels in post-CABG pleural effusions are associated with pleural inflammation and permeability. (2007) (9)
The Impact of Gravity versus Suction-driven Therapeutic Thoracentesis on Pressure-related Complications: the GRAVITAS Multicenter Randomized Controlled Trial. (2019) (8)
Adenosine deaminase for lymphocytic pleural effusions (2004) (8)
Use of pleural fluid N-terminal-pro-brain natriuretic peptide and brain natriuretic peptide in diagnosing pleural effusion due to congestive heart failure. (2009) (8)
Usefulness of Triglyceride Levels in Pleural Fluid (2010) (8)
Effectiveness of Ethanolamine Oleate as a Pleural Sclerosing Agent in Rabbits (1998) (7)
A new method for analyzing multiple-breath nitrogen washout curves. (1980) (7)
Distribution of pleural injectate. Effect of volume of injectate and animal rotation. (1994) (7)
New trends in the diagnosis and treatment in parapneumonic effusion and empyema. (2008) (7)
Mediastinal abscess secondary to vertebral osteomyelitis. (1982) (7)
Severe slowly resolving heroin-induced pulmonary edema. (1975) (7)
Management of Empyema (1992) (7)
Líquido pleural de color negro (2009) (7)
The Impact of Gravity vs Suction-driven Therapeutic Thoracentesis on Pressure-related Complications (2020) (7)
Intrapleural heparin or heparin combined with human recombinant DNase is not effective in the treatment of empyema in a rabbit model (2006) (7)
New agents for pleurodesis (2013) (7)
New Treatment for Hepatic Hydrothorax? (2016) (7)
Cefazolin vs penicillin. Treatment of uncomplicated pneumococcal pneumonia. (1979) (6)
Research: Why and how to write a paper? (2015) (6)
A new diagnostic approach for bilious pleural effusion. (2016) (6)
79 – Pleural Effusion (2016) (6)
Apex-to-Cupola Distance Following VATS Predicts Recurrence in Patients With Primary Spontaneous Pneumothorax (2015) (6)
Pleurodesis: what agent should be used? (2003) (6)
Response of patients with chronic obstructive lung disease to the regular administration of nebulized isoproterenol. A double-blind crossover study. (1975) (6)
The Use of Different Cutoff Values of ADA Liquid Level in Diagnosis of Tuberculous Pleurisy in Countries With Different Incidence of Tuberculosis (2011) (6)
Is Talc Indicated for Pleurodesis?: Con: Talc Should Not be Used for Pleurodesis (2002) (6)
The Legend of the Buffalo Chest (2021) (6)
Pleural Fluid Analysis: Are Light's Criteria Still Relevant After Half a Century? (2021) (5)
Prevalence of pleural effusions post orthotopic heart transplantation (2007) (5)
Pleural Fluid Eosinophilia in Malignant and Benign Hemorrhagic Pleural Effusion (2003) (5)
Effect of pneumothorax on pleurodesis induced with talc in rabbits. (1998) (5)
Does therapeutic thoracentesis improve the exercise capacity of patients with pleural effusion (1987) (5)
Parapneumonic Effusion (2010) (5)
Closed Needle Biopsy of the Pleura is a Valuable Diagnostic Procedure (1998) (5)
Update: Management of Parapneumonic Effusions (2003) (5)
Granulomatous pleuritis secondary to blastomycosis. (1977) (5)
[Effect of anti-vascular endothelial growth factor antibody on pleurodesis induced by transforming growth factor-beta or doxycycline in rabbits]. (2006) (5)
D-dimer levels in pleural effusions. (2006) (4)
Ischemia Modified Albumin In The Differential Diagnosis Of Pleural Effusions (2011) (4)
Hypoxemia and pulmonary dysfunction associated with delirium tremens. (1983) (4)
Relative value of tests used to measure bronchodilator response. (1978) (4)
Pleural-Fluid Lactic Acid Dehydrogenase and Protein Content. (1972) (4)
Nitrobule tetrazolium test in the diagnosis of pleural effusions. (1981) (4)
Diagnosing empyema in children. (2007) (4)
Rebuttal from dr. light (2012) (4)
Maximum inspiratory muscle endurance capacity during resistive loading in chronic obstructive pulmonary disease. (1990) (4)
Effects of sodium bicarbonate administration on the exercise tolerance of normal subjects breathing through dead space. (1999) (4)
Upper airway obstruction. (1977) (4)
The effects of erythromycin on the viability and the secretion of TNF‐α and TGF‐β1 and expression of connexin43 by human pleural mesothelial cells (2005) (4)
Arrhythmogenic effects of combined orally administered theophylline and albuterol in patients with chronic obstructive pulmonary disease. (1994) (3)
Comparison of mitoxantrone and tetracycline as pleural sclerosing agents in rabbits (2004) (3)
BIOMARKERS OF INFLAMMATION AND COAGULOPATHY PREDICT THE DURATION OF ACUTE BRAIN DYSFUNCTION IN CRITICALLY ILL PATIENTS.: 75 (2006) (3)
Lactate Dehydrogenase Isoenzymes in Pleural Effusions1 (2015) (3)
Mice are resistant to the induction of a pleurodesis. (2003) (3)
Effectiveness of sodium hydroxide as a pleural sclerosing agent in rabbits: Influence of concomitant intrapleural lidocaine (2004) (3)
Management of the Undiagnosed Persistent Pleural Effusion (2004) (3)
The effects of pentoxifylline on oxygenation, diffusion of carbon monoxide, and exercise tolerance in patients with COPD. (1995) (3)
Comparison of albuterol and isoproterenol aerosols in bronchial asthma. (1977) (3)
Diagnostic clue for pleural metastasis of malignant melanoma (2018) (3)
Exercise‐induced changes in left ventricular function after phlebotomy in patients with polycythemic COPD (1990) (3)
Diagnostic Pitfalls of Discriminating Lymphoma-Associated Effusions (2015) (3)
Abrasion Plus Local Fibrin Sealant Instillation Produces Pleurodesis Similar to Pleurectomy in Rabbits. (2016) (3)
Do Viral Infections Cause Pleural Effusions (2009) (2)
Physiology: changes with pleural effusion and pneumothorax (2008) (2)
Differentiation between malignant and non-malignant pleural effusion using cancer ratio and other new parameters. (2018) (2)
Pleural fluid exchange in rabbits (2007) (2)
Pharmacokinetics and Pharmacodynamics in Pleural Fluid (2004) (2)
Specificity of immunosuppression by human alveolar cells. (1984) (2)
GRAVITY VS SUCTION-DRIVEN THERAPEUTIC THORACENTESIS TO PREVENT PLEURAL-PRESSURE-RELATED COMPLICATIONS: THE GRAVITAS MULTICENTER RANDOMIZED CONTROLLED TRIAL (2019) (2)
PITFALL IN THE PCO2 GRADIENT. AUTHOR'S REPLY (1996) (2)
Coulter counter registers talc particles as leukocytes. (2001) (2)
Transbronchial Needle Aspiration: Asian-Pacific Experience (2004) (2)
Incidence of Pleural Effusions in Patients With Portopulmonary Hypertension (2010) (2)
Is It a Safer Method (2015) (2)
Conversion of COPD patients from multiple to single dose theophylline. Serum levels and symptom comparison. (1991) (2)
Management of parapneumonic effusion in pregnant women. (2018) (2)
Letter: Low pleural fluid pH in parapneumonic effusion. (1975) (2)
Successful factor XIII treatment of refractory chylothorax in tuberous sclerosis complex-associated lymphangioleiomyomatosis, multifocal multinodular pneumocyte hyperplasia and mediastinal lymphadenopathy. (2017) (2)
Airway Occlusion Pressure (2015) (2)
Effusions after surgery (2008) (2)
Magnitude of Ventilatory Reserve at Exhaustion (1989) (2)
Vena caval thromboses. (2010) (2)
Pleurodesis Induced by Oral Forms of Tetracycline and Doxycycline in Rabbits (2004) (2)
Black pleural fluid (2009) (2)
Amelanotic Malignant Melanoma with Dense Pleural Thickening Mimicking Malignant Mesothelioma (2018) (1)
[Black pleural fluid]. (2009) (1)
[Diagnosis of pleural tuberculosis]. (1999) (1)
PLEURAL FLUID ACCUMULATION IN CHILDREN WITH UNIVENTRICULAR CONGENITAL HEART DISEASE: THE APPLICATION OF LIGHT'S CRITERIA AFTER THE GLENN AND FONTAN PALLIATION (2013) (1)
Comprar Textbook of Pleural Diseases | Lee, Gary | 9780340940174 | Hodder Arnold (2008) (1)
Epidemiology of atypical mycobacterial disease in Texas and Louisiana. (1976) (1)
Approach to the diagnosis of secondary pulmonary hypertension: the chest roentgenogram as a diagnostic tool. (1986) (1)
Chapter 6.2. Pleural Disease (2007) (1)
THE BLOOD-PATCH TECHNIQUE FOR PERSISTENT AIRLEAKS (2012) (1)
SEVERE INTRAPULMONARY SHUNTING IN BRONCHIOLOALVEOLAR CELL CARCINOMA CORRECTED BY SELECTIVE PULMONARY ARTERY OCCLUSION AND PALLIATIVE TUMOR RESECTION (2006) (1)
The use of labetalol for the treatment of hypertension in patients with reversible airway obstruction. (1985) (1)
KARŞIT GÖRÜŞ (PRO-CON): TALK KÖTÜDÜR (TALC IS NOT GOOD FOR PLEURODESIS) (2009) (1)
Clinical effects of albuterol aerosol in the treatment of asthma. (1981) (1)
Optimal dose of fenoterol by metered-dose inhaler in asthmatic adults. (1986) (1)
PLEURAL EFFUSIONS | Overview (2006) (1)
Theophylline-ranitidine interaction in elderly COPD patients. (1995) (1)
Clinical Diagnosis of Pleural Disease (2008) (1)
Right Ventricular Dysfunction and Its Relationship to Maximal Oxygen Consumption of Patients with Chronic Obstructive Pulmonary Disease (1989) (1)
SOLUBLE TREM-1 (TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS) IN PLEURAL EFFUSIONS: A MARKER OF INFECTIOUS DISEASE (2007) (1)
Massive pulmonary embolism complicating streptokinase treatment for deep vein thrombosis. (1987) (1)
Pleural Effusion: Transudate vs Exudate (2006) (1)
A Novel Marker for Cell-Mediated Immunity in Patients With Pulmonary Tuberculosis and Lung Cancer (2017) (1)
Contribution of IL-5 and IL-13 in Pneumothorax-associated Pleural Eosinophili (2003) (1)
[Heparin induced thrombocytopenia: how to manage when the patient is pregnant?]. (2005) (1)
Effusions from vascular causes (2008) (1)
Hepatic mycobacterial disease and aids (1990) (1)
Proteomic Profiles Diagnostic For Malignant Pleural Effusions (2004) (0)
PLEURAL EFFUSIONS | Postsurgical Effusions (2006) (0)
Faculty Opinions recommendation of Efficacy and safety of iodopovidone pleurodesis through tube thoracostomy. (2006) (0)
Human Pulmonary Dirofilariasis: Entry Method of Infective Larvae (2017) (0)
Complicated Pleural Effusion in Community-Acquired Pneumonia (2002) (0)
WhatIs the Originof Pleural Transudates andExudates (2017) (0)
How does pleurodesis affect lung function (2001) (0)
Do Different Doses of Talc Influence the Acute Systemic Inflammatory Response in Experimental Pleurodesis (2003) (0)
Arterial BloodGasChanges During Breath-holding FromFunctional Residual (2015) (0)
Treatment of pneumococcal pneumonia: a comparison of penicillin and cefazolin (1977) (0)
The reply. (2013) (0)
Systemic inflammatory repercussions after pleurodesis in an experimental model of pneumothorax (2013) (0)
Pulmonary Fungal and Nocardial Infections (2017) (0)
Diseases of the pleura. (1995) (0)
XI: Management of pleural effusions (1985) (0)
Faculty Opinions recommendation of Novel use of pleural ultrasound can identify malignant entrapped lung prior to effusion drainage. (2017) (0)
Measurements of membrane diffusing capacity and pulmonary capillary blood volume in normal subjects and patients with mild emphysema. (1996) (0)
PLEURAL EFFUSIONS | Pleural Fluid, Transudate and Exudate (2006) (0)
Management of Pleural Effusion in the Pulmonary Sepsis (2004) (0)
Nitroblue Tetrazolium Test in the Diagnosis CHEST , 80 : 1 , JULY , 1981 DIAGNOSIS OF PLEURAL EFFUSIONS 39 of Pleural Effusions * (2006) (0)
The Acute Effects of Talc Slurry Pleurodesis in Rabbit Model (2000) (0)
C Reactive Protein a Useful Biomarker in Diagnosis of Pleural Effusion (2014) (0)
Goose-skin Pleura: A Thoracoscopic Finding in a Case of Recurrent Undiagnosed Pleural Effusion. (2010) (0)
Pleural effusion associated with pulmonary embolization. (1985) (0)
Intrapleural talc in the management of pleural effusion due to breast cancer (1994) (0)
Characteristics Of Pleural Effusions In Patients Undergoing The Fontan Or Glenn Procedures For Congenital Cardiac Defects (2011) (0)
Method for preserving a hemoglobin blood replacement agent (1999) (0)
Pediatric pleural diseases Elizabeth A Perkett and Paul E Moore (2008) (0)
[The effects of intrapleural anti-TNFalpha antibody on chemical pleurodesis induced by talc slurry or doxycycline]. (2001) (0)
Effect of rotation on distribution of injectate after intrapleural injection (1993) (0)
Pleural effusions. (1977) (0)
Nutritional status and arterial desaturation during meals in patients with chronic lung disease (1983) (0)
Intrapleural talc for the treatment of benign and undiagnosed pleural effusions (1994) (0)
Intrapleural Tetracycline for Recurrent Pneumothorax-Reply (1991) (0)
Preserving a hemoglobin blood-substitute by a transparent outer package (2000) (0)
Pleural disease. (1996) (0)
Correlation between radiographic indices and radio nuclide right ventricular ejection fractions in patients with chronic obstructive pulmonary disease (1983) (0)
[Indwelling catheter for the management of malign pleural effusions]. (2005) (0)
[Advances in the management of parapneumonia pleural effusion]. (1996) (0)
Effusions of obstetric or gynecological origin (2008) (0)
Pleural Sclerosis for the Management of Initial Pneumothorax (2007) (0)
Are Large Primary Spontaneous Pneumothoraces Always a Surgical Alternative (2012) (0)
INTRAPLEURAL INJECTION OF AIR OR SALINE CAUSES SIGNIFICANT PLEURAL EOSINOPHILIA IN MICE (2008) (0)
Phase 1a/1b Dose-escalation Trial of Intrapleural LTI-01 (Single Chain Urokinase/scuPA) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema (2019) (0)
INTRAPLEURAL HEPARIN OR HEPARIN COMBINED WITH HUMAN RECOMBINANT DNAASE IS NOT EFFECTIVE IN THE TREATMENT OF EMPYEMA IN A RABBIT MODEL (2005) (0)
Intrapleural and Plasma Processing of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) in a Phase 1b Trial of LTI-01 Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema (2019) (0)
Faculty Opinions recommendation of The diagnostic performance of routinely acquired and reported computed tomography imaging in patients presenting with suspected pleural malignancy. (2017) (0)
Mechanisms controlling arterial oxygen saturation in patients with chronic obstructive lung disease in the standing position (1979) (0)
International Pleural Newsletter Vol 4 Issue 2 (2006) (0)
Transforming Growth Factor-Beta: A Potential New Agent for Pleurodesis (2005) (0)
Subject Index Vol. 76, 2008 (2008) (0)
Significance of latrogenic Pneumothoraces (2017) (0)
TÜBERKÜLOZ ve TORAKS TUBERCULOSIS and THORAX (2011) (0)
Being Sensitive to the Specifics of Predictive Values in the Diagnosis of Tuberculous Pleuritis (1999) (0)
Oral atropine in the treatment of chronic asthma. (1977) (0)
A Grocery Store Item for Pleurodesis (2004) (0)
Evolution of Hemorrhagic Post-coronary artery bypass Graft Pleural Effusion (2003) (0)
INTRAPLEURAL TETRACYCLINE FOR RECURRENT PENUMOTHORAX. AUTHOR'S REPLY (1991) (0)
80 – Pleural Infections (2016) (0)
Influenceof Atelectasis on Pulmonary FunctionAfterCoronaryArteryBypass Grafting (2017) (0)
Diseases of the pleura. (1997) (0)
Announcing a New Journal: PLEURA (2014) (0)
Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema (2019) (0)
Acknowledgement to the Reviewers (2002) (0)
Animal Models in Pleural Investigation (2004) (0)
Tests of Bronchodilator Therapy (1978) (0)
Contents Vol. 76, 2008 (2008) (0)
Management of transudative effusions (1995) (0)
How to Conduct a Pleural Research: Master's Advice. (2016) (0)
The Evolution Of Parapneumonic Effusions In Patients Hospitalized For Community-Acquired Pneumonia (2011) (0)
Reproducibility of in Patients with Chronic Air-flow Obstruction1,2 (2015) (0)
Pleural Effusion : Diagnosis and Management of Causative Disorders Series (2002) (0)
sampled?size parapneumonic effusions should be (2010) (0)
The Effect of Anti-Vascular Endothelial Growth Factor Antibody on Pleurodesis Induced by Transforming Growth Factor beta in Rabbits (2003) (0)
Uluslararasi Danişma Kurulu/International Advisory Board (2014) (0)
Roentgenogram of the month: thoracic mass and pleuritic chest pain. (1979) (0)
e V ective pleurodesis in sheep with no systemic complications (2000) (0)
TISSUE PLASMINOGEN ACTIVATOR INCREASES THE VOLUME OF PLEURAL FLUID BY INFLAMMATORY RESPONSES IN RABBITS WITH EMPYEMA (2005) (0)
Influenceof Atelectasison Pulmonary FunctionAfter CoronaryArtery Bypass Grafting * (2006) (0)
The Relationship Between Deadspace/Tidal Volume Ratio and Pulmonary Hemodynamics During Exercise in Chronic Airflow Obstruction (1990) (0)
Daptomycin-Induced Eosinophilic Pneumonia (2011) (0)
Investidura com a doctor Honoris Causa del senyor Richard Wayne Light (2010) (0)
Heparine bağli trombositopeni: Hasta gebe ise nasil tedavi edilmeli? (2005) (0)
Effect ofPneumothorax on Pleurodesis Induced WithTalcinRabbits (2015) (0)
Pleural diseases. (2003) (0)
Comprar Pleural Diseases 5/e | Richard W. Light | 9780781769570 | Lippincott Williams & Wilkins (2007) (0)
Effectiveness of silver nitrate as pleural sclerosing agent in rabbits (1995) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Richard W. Light?

Richard W. Light is affiliated with the following schools: